InvestorsHub Logo
Followers 75
Posts 9167
Boards Moderated 0
Alias Born 04/25/2002

Re: White chocolate 250 post# 36003

Sunday, 07/23/2023 3:41:53 PM

Sunday, July 23, 2023 3:41:53 PM

Post# of 36581
White Choc.... I agree. At least 2 years ago multiple leading scientists announced that 'historically' viruses become weaker and weaker as they mutate over time. Hence, all of the talk about how the delta virus will eventually mutate and be treated as a common winter flu. This is exactly what happened.

And.... over that period of time standard of care (SOC) continued to improve. So biotech therapies during their FDA studies were constantly competing against improving SOC. IMO it was improving SOC is what took the legs out of most biotech FDA covid studies. As far as I could tell, most FDA studies for covid did not 100% decouple their primary endpoints from SOC. Investors who made a lot of $$ on the covid biotech sector did so by selling 'on the hype'. Those that lost $$ typically were those that held their shares down to the end (FDA trial completions).

Now RVVTF must dump/dilute more shares to keep paying their high compensation packages. The O/S and float will continue to grow. I now only see one undesirable outcome for this when MF and other officers realize that they need to re-energize this cash cow machine while they continue to pursue the DREAM of actually generating sales from a real product. Shroom sales just won't cut it IMO.